AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...
The Sleep Disorder Treatment Market is rapidly evolving, driven by a surge in demand for effective treatment options and innovative technologies to address the global sleep crisis.Austin, Oct. 22, ...